Literature DB >> 15453543

Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase.

Salvador Huitron-Resendiz1, Manuel Sanchez-Alavez, Derek N Wills, Benjamin F Cravatt, Steven J Henriksen.   

Abstract

STUDY
OBJECTIVES: Oleamide and anandamide are fatty acid amides implicated in the regulatory mechanisms of sleep processes. However, due to their prompt catabolism by fatty acid amide hydrolase (FAAH), their pharmacologic and behavioral effects, in vivo, disappear rapidly. To determine if, in the absence of FAAH, the hypnogenic fatty acid amides induce an increase of sleep, we characterized the sleep-wake patters in FAAH-knockout mice [FAAH (-/-)] before and after sleep deprivation.
DESIGN: FAAH (-/-), FAAH (+/-), and FAAH (+/+) mice were implanted chronically for sleep, body temperature (Tb), and locomotor activity (LMA) recordings. Sleep-wake states were recorded during a 24-hour baseline session followed by 8 hours of sleep deprivation. Recovery recordings were done during the 16 hours following sleep deprivation. Total amount of wake, slow-wave sleep, and rapid eye movement sleep were calculated and compared between genotypes. The electroencephalographic spectral analysis was performed by fast Fourier transform analysis. Telemetry recordings of Tb and LMA were carried out continuously during 4 days under baseline conditions.
SETTING: N/A. PATIENTS OR PARTICIPANTS: FAAH (-/-) mice and their heterozygote (+/-) and control (+/+) littermates were used.
INTERVENTIONS: Sleep deprivation. MEASUREMENTS AND
RESULTS: FAAH (-/-) mice possess higher values of slow-wave sleep and more intense episodes of slow-wave sleep than do control littermates under baseline conditions that are not related to differences in Tb and LMA. A rebound of slow-wave sleep and rapid eye movement sleep as well an increase in the levels of slow-wave activity were observed after sleep deprivation in all genotypes.
CONCLUSION: These findings support the role of fatty acid amides as possible modulators of sleep and indicate that the homeostatic mechanisms of sleep in FAAH (-/-) mice are not disrupted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15453543     DOI: 10.1093/sleep/27.5.857

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  33 in total

1.  Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Authors:  Jessica K DeMartino; Joie Garfunkle; Dustin G Hochstatter; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

Review 2.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

Review 3.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 4.  Mammalian sleep genetics.

Authors:  Jessica M Kelly; Matt T Bianchi
Journal:  Neurogenetics       Date:  2012-09-14       Impact factor: 2.660

5.  Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.

Authors:  Gai Ling Li; Helen Winter; Rosalin Arends; Gary W Jay; Vu Le; Tim Young; John P Huggins
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

6.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

7.  Altered brain activity during withdrawal from chronic alcohol is associated with changes in IL-6 signal transduction and GABAergic mechanisms in transgenic mice with increased astrocyte expression of IL-6.

Authors:  Donna L Gruol; Salvador Huitron-Resendiz; Amanda J Roberts
Journal:  Neuropharmacology       Date:  2018-05-19       Impact factor: 5.250

8.  N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice.

Authors:  Giulia Donvito; Fabiana Piscitelli; Pretal Muldoon; Asti Jackson; Rosa Maria Vitale; Enrico D'Aniello; Catia Giordano; Bogna M Ignatowska-Jankowska; Mohammed A Mustafa; Francesca Guida; Gavin N Petrie; Linda Parker; Reem Smoum; Laura Sim-Selley; Sabatino Maione; Aron H Lichtman; M Imad Damaj; Vincenzo Di Marzo; Raphael Mechoulam
Journal:  Neuropharmacology       Date:  2018-03-19       Impact factor: 5.250

9.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

10.  More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.

Authors:  Andrea M Dlugos; Ajna Hamidovic; Colin A Hodgkinson; David Goldman; Abraham A Palmer; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.